Impact of lockdown and non-pharmaceutical interventions on the epidemiology of Legionnaires' disease.

Matteo Riccò
Author Information
  1. Matteo Riccò: Azienda USL di Reggio EmiliaV.le Amendola n.2 - 42122 REServizio di Prevenzione e Sicurezza negli Ambienti di Lavoro (SPSAL)Dip. di Prevenzione. mricco2000@gmail.com.

Abstract

BACKGROUND AND AIM: In order to cope with the requirements of COVID-19 pandemic and prevent overwhelming of the healthcare systems, during 2020 social distancing measures were proposed, and generalized lockdown. Aim of our study is to ascertain whether non-pharmaceutical intervention did have any impact on the epidemiology of Legionnaires' disease (LD), a respiratory infectious disease without interhuman spreading.
METHODS: Official national reports from 4 index countries in European Union (i.e. Germany, France, Italy, and Spain) were retrieved. The study included all cases notified during 2020 COVID-19 outbreak, versus the cases referred during the same period in 2019. Subgroup analyses for hospital-associated and travel-associated LD cases, as well as for lethality estimates were performed.
RESULTS: A sustained drop for incidence rate was confirmed, at EU-level (3.5 per 100,000 vs. 5.3 per 100,000) as well as in the national estimates. The decrease was particularly evident in Italy (RR 0.880, 95%CI 0.839 to 0.905), despite a transient surge in notification rates during the month of June, 2020. Subgroup analyses demonstrated a fall in travel-associated cases (-66.8% at EU level), while hospital-associated cases decreased in absolute number when compared to 2019, but where substantially stable in terms when compared to EU estimates. While Case Fatality Ratio increased in comparison with 2019, no significant trend was similarly identified in comparison to EU estimates.  Conclusions. Lockdown measures have impacted on the epidemiology of LD in Europe during 2020, but some heterogeneities were identified both across the assessed countries, and the various subgroup. Even though the absolute number of total cases did substantially decrease in 2020 compared to 2019, the effect of non-pharmaceutical interventions was mostly indirect, through a reduced interaction of individuals with environments at potentially high-risk for human infections (e.g. hospitals, accommodation sites, etc.).

References

  1. Environ Res. 2017 Jan;152:485-495 [PMID: 27717486]
  2. Nephrol Dial Transplant. 2016 Jun;31(6):882-5 [PMID: 27217394]
  3. Euro Surveill. 2020 Apr;25(13): [PMID: 32265003]
  4. Euro Surveill. 2020 Jul;25(30): [PMID: 32734857]
  5. Diagnostics (Basel). 2021 Jul 02;11(7): [PMID: 34359283]
  6. Nature. 2020 Aug;584(7820):257-261 [PMID: 32512579]
  7. N Engl J Med. 2001 Jun 21;344(25):1917-28 [PMID: 11419430]
  8. Microorganisms. 2021 Oct 20;9(11): [PMID: 34835307]
  9. Euro Surveill. 2020 May;25(20): [PMID: 32458793]
  10. PLoS One. 2019 Jul 9;14(7):e0218687 [PMID: 31287819]
  11. Trop Med Infect Dis. 2021 Jun 29;6(3): [PMID: 34209481]
  12. Lancet Reg Health Eur. 2021 Jun 19;6:100103 [PMID: 34557831]
  13. Pneumonia (Nathan). 2021 Jan 6;13(1):2 [PMID: 33407911]
  14. Infect Dis Clin North Am. 2017 Mar;31(1):7-27 [PMID: 28159177]
  15. N Engl J Med. 2009 Feb 5;360(6):588-98 [PMID: 19196675]
  16. Curr Opin Infect Dis. 2018 Aug;31(4):325-333 [PMID: 29794542]
  17. Ann Ist Super Sanita. 2021 Jul-Sep;57(3):199-200 [PMID: 34554112]
  18. J Travel Med. 2020 Dec 23;27(8): [PMID: 33152761]
  19. JAMA Netw Open. 2020 Jan 3;3(1):e1919325 [PMID: 31922554]
  20. Environ Res. 2018 Oct;166:55-60 [PMID: 29864633]
  21. Lancet. 2016 Jan 23;387(10016):376-385 [PMID: 26231463]
  22. Infect Genet Evol. 2016 Sep;43:108-22 [PMID: 27180896]
  23. J Travel Med. 2015 Sep-Oct;22(5):325-37 [PMID: 26220258]
  24. Trends Microbiol. 2021 Sep;29(9):860-861 [PMID: 33994277]
  25. Int J Environ Res Public Health. 2021 Mar 14;18(6): [PMID: 33799417]
  26. Lancet Reg Health Eur. 2021 Jul;6:100139 [PMID: 34223441]
  27. PLoS Pathog. 2009 Jul;5(7):e1000508 [PMID: 19593377]
  28. Sci Rep. 2020 Apr 30;10(1):7337 [PMID: 32355282]
  29. Int J Hyg Environ Health. 2006 Nov;209(6):547-52 [PMID: 16815095]
  30. Ann Ig. 2019 Sep-Oct;31(5):474-481 [PMID: 31304527]
  31. MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257 [PMID: 32915166]

MeSH Term

COVID-19
Communicable Disease Control
Humans
Legionnaires' Disease
Pandemics
Travel

Word Cloud

Created with Highcharts 10.0.0cases20202019estimatesnon-pharmaceuticalepidemiologydiseaseLD0EUcomparedCOVID-19measureslockdownstudyLegionnaires'nationalcountrieseItalySubgroupanalyseshospital-associatedtravel-associatedwell35per100000decreaseabsolutenumbersubstantiallycomparisonidentifiedinterventionsBACKGROUNDANDAIM:ordercoperequirementspandemicpreventoverwhelminghealthcaresystemssocialdistancingproposedgeneralizedAimascertainwhetherinterventionimpactrespiratoryinfectiouswithoutinterhumanspreadingMETHODS:Officialreports4indexEuropeanUnioniGermanyFranceSpainretrievedincludednotifiedoutbreakversusreferredperiodlethalityperformedRESULTS:sustaineddropincidencerateconfirmedEU-levelvsparticularlyevidentRR88095%CI839905despitetransientsurgenotificationratesmonthJunedemonstratedfall-668%leveldecreasedstabletermsCaseFatalityRatioincreasedsignificanttrendsimilarly ConclusionsLockdownimpactedEuropeheterogeneitiesacrossassessedvarioussubgroupEventhoughtotaleffectmostlyindirectreducedinteractionindividualsenvironmentspotentiallyhigh-riskhumaninfectionsghospitalsaccommodationsitesetcImpact

Similar Articles

Cited By